SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-23-000077
Filing Date
2023-08-09
Accepted
2023-08-09 16:03:59
Documents
83
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q smmt-20230630.htm   iXBRL 10-Q 1045081
2 EX-31.1 sum-ex311_20230630xduggan.htm EX-31.1 11813
3 EX-31.2 sum-ex312_20230630xzanganeh.htm EX-31.2 11888
4 EX-31.3 sum-ex313_20230630xdhingra.htm EX-31.3 11896
5 EX-32.1 sum-ex321_20230630x10q.htm EX-32.1 11041
  Complete submission text file 0001599298-23-000077.txt   6290214

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20230630.xsd EX-101.SCH 55784
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20230630_cal.xml EX-101.CAL 69954
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20230630_def.xml EX-101.DEF 219468
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20230630_lab.xml EX-101.LAB 576774
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20230630_pre.xml EX-101.PRE 412448
77 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20230630_htm.xml XML 772988
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36866 | Film No.: 231155034
SIC: 2834 Pharmaceutical Preparations